CABG Medical, Inc. Announces Pricing of Public Offering
December 07 2004 - 4:30PM
PR Newswire (US)
CABG Medical, Inc. Announces Pricing of Public Offering
MINNEAPOLIS, Dec. 7 /PRNewswire-FirstCall/ -- CABG Medical, Inc.
(NASDAQ:CABG), a medical technology company seeking to improve the
treatment of coronary heart disease by advancing conventional
bypass surgery, today announced its public offering of 5,500,000
shares of common stock at a price of $5.50 per share. CABG Medical,
Inc. has granted to the underwriters an option to purchase up to an
additional 825,000 shares of common stock to cover over-allotments,
if any. Feltl and Company and Ladenburg Thalmann & Co. Inc.
serve as co-managers of the offering. The shares will be listed on
the Nasdaq Stock Market's National Market under the symbol "CABG."
The common stock offering may be made only by means of a
prospectus, copies of which may be obtained by contacting Feltl and
Company at 225 South Sixth Street, Suite 4200, Minneapolis,
Minnesota 55402 or Ladenburg Thalmann & Co. Inc. at 590 Madison
Avenue, New York, New York 10022. A registration statement relating
to these securities was declared effective by the Securities and
Exchange Commission on December 7, 2004. This press release shall
not constitute an offer to sell or the solicitation of an offer to
buy, nor shall there be any sale of these securities in any state
or jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. About the
Company: CABG Medical, Inc., headquartered in Minneapolis,
Minnesota, is a medical technology company seeking to improve the
treatment of coronary heart disease by advancing conventional
bypass surgery. We have designed our first product, the Holly Graft
System, by leveraging our understanding of flow dynamics, material
sciences and drug combinations to create an artificial coronary
graft system. We are led by a team of experienced medical
technology industry executives and recognized experts in cardiac
surgery and cardiovascular research. DATASOURCE: CABG Medical, Inc.
CONTACT: Manny Villafana, Chairman and Chief Executive Officer of
CABG Medical, Inc., +1-763-258-8005 Web site:
http://www.cabgmedical.com/
Copyright